Sigma-Aldrich last week named Patrick Sullivan vice president of R&D for the research biotech business unit. His appointment became effective Oct. 1. In his position, he will “help expand Sigma-Aldrich’s leadership position through the development of new and innovative products for life science researchers,” the company said in a statement. He will report to David Smoller, the company’s president of research biotech.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.